Glanbia acquires Seltzer
This article was originally published in The Tan Sheet
Executive Summary
Consumer foods and ingredients firm Glanbia plc will further develop its international nutritionals business and enter "key global growth markets" through its acquisition of Calif-based Seltzer Companies, according to Glanbia's Group Managing Director John Maloney. Currently, the international firm's major U.S. presence is in the dairy market, according to Glanbia's website. The firm also produces the branded whey protein isolate BarFlex in the U.S. and has several other branded whey and milk-based ingredients. In addition to increasing its global presence, the purchase also "creates the opportunity to extend Glanbia's major investment in innovation and clinical research in nutritional products with science-based health benefits," the firm states in a Sept. 6 release. The $105 mil. transaction awaits FTC approval and Glanbia expects completion of the deal in October. Wayne Seltzer will continue to run the Seltzer business, Glanbia adds...
You may also be interested in...
Glanbia acquires Optimum Nutrition
With its $315 million purchase of sports nutritional supplement firm Optimum Nutrition, Kilkenny, Ireland-based Glanbia continues to internationalize its business, according to an Aug. 25 release. Glanbia Group Managing Director John Moloney says the deal gives Glanbia "a leading position of scale in a fast- growing segment of the nutrition market." Optimum Nutrition brands such as Gold Standard 100% Whey also bring Glanbia "up the value chain into consumer markets," Moloney says. In September 2006, the firm expanded its U.S. presence by acquiring nutritional products business Seltzer Companies (1"The Tan Sheet" Sept. 11, 2006, In Brief)
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.